Abstract
Introduction: Remote monitoring technology has the potential to guide adjustments in NIV therapy, monitor adherence to treatment and reduce the burden of hospital visits.
Aim: To determine the feasibility and impact of remote monitoring following outpatient NIV set-up.
Method: Between January and September 2016 new patients requiring NIV were offered monitoring of their NIV via modem.
A secure online system (EncoreAnywhere, Philips Respironics®) was used to monitor modem data. Modem data checks were planned three times weekly for 3 months following set-up.
Results: 18 patients with ventilatory failure due to neuromuscular weakness, chest wall deformity, obesity or COPD agreed to take part.
Modems were monitored for an average of 64 days following NIV set-up (range 4-138). Reasons for stopping monitoring included death, stability at first outpatient review and lack of staff time. Modems were checked every 5 days on average.
A total of 223 modem checks were performed, 60 (27%) required intervention; see Figure 1 for details. Eleven of these actions were likely to have prevented a hospital visit.
Patient satisfaction questionnaires were returned from 7 patients and were strongly positive.
Conclusion: Remote monitoring reduced the requirment for hospital visits and was liked by patients. Our planned frequency of data review was unrealistic, and further work is required to determine the optimal frequency and length of monitoring.
Footnotes
Cite this article as: European Respiratory Journal 2018 52: Suppl. 62, PA1669.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2018
